Berlin, Germany
Labiotech.eu stands out as Europe’s premier digital media platform dedicated to the global biotech industry. Since its founding in 2014, the company has established itself as a trusted source for over 130,000 monthly readers, predominantly professionals in the biopharma sector, who seek insightful articles and detailed analyses of industry trends.
Headquartered in Germany, Labiotech.eu offers a robust array of daily articles, in-depth content, and an extensive archive, making it a go-to resource for anyone looking to stay ahead in the dynamic biotech field.
The company's last known funding event was an acquisition investment on 01 January 2022 by Inpart, which underscores strategic interest and confidence in its value proposition. As the biotech industry's influence expands globally, Labiotech.eu is strategically positioned to capitalize on increasing demand for quality information and analysis within this sphere.
